(Q33310422)

English

Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

0 references

1 reference

based on heuristic

inferred from title

neurodegeneration

1 reference

based on heuristic

inferred from title

author name string

R M Moresco

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

T Lavazza

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

S Belloli

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M Lecchi

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A Pezzola

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

S Todde

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M Matarrese

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A Carpinelli

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

E Turolla

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

V Zimarino

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

P Popoli

11

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A Malgaroli

12

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

F Fazio

13

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

15 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

704-715

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Huntington's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Selective neuronal degeneration in Huntington's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Progressive behavioural changes in the spatial open-field in the quinolinic acid rat model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Protective effects of neurotrophin-4/5 and transforming growth factor-alpha on striatal neuronal phenotypic degeneration after excitotoxic lesioning with quinolinic acid

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Early and progressive accumulation of reactive microglia in the Huntington disease brain

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Microglia density decreases with age in a mouse model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Human microglia convert l-tryptophan into the neurotoxin quinolinic acid

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Positron Emission Tomography: applications in drug discovery and drug development

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Using positron emission tomography to facilitate CNS drug development

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Evaluation of three quinoline-carboxamide derivatives as potential radioligands for the in vivo pet imaging of neurodegeneration.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

In vivo imaging of adenosine A2A receptors in rat and primate brain using [11C]SCH442416.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Remote microglial activation in the quinolinic acid model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Labeling and evaluation of N-[11C]methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A(2A) receptor system using positron emission tomography

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Temporal profile of subventricular zone progenitor cell migration following quinolinic acid-induced striatal cell loss.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Effects of dopamine on the in vivo binding of dopamine D2 receptor radioligands in rat striatum

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Positron emission tomography and ex vivo and in vitro autoradiography studies on dopamine D2-like receptor degeneration in the quinolinic acid-lesioned rat striatum: comparison of [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperone

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Adenosine A2A receptors in bone marrow-derived cells but not in forebrain neurons are important contributors to 3-nitropropionic acid-induced striatal damage as revealed by cell-type-selective inactivation.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Evidence for dopamine D2 receptor mRNA expression by striatal astrocytes in culture: in situ hybridization and polymerase chain reaction studies

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

An astroglia-linked dopamine D2-receptor action in prefrontal cortex

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Acute 3-nitropropionic acid intoxication induces striatal astrocytic cell death and dysfunction of the blood-brain barrier: involvement of dopamine toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Molecular mechanisms of microglial activation. A. Implications for regeneration and neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Time course of glial proliferation and glial apoptosis following excitotoxic CNS injury

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Imaging brain inflammation with [(11)C]PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Microglial activation correlates with severity in Huntington disease: a clinical and PET study.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Inhibitors of the kynurenine pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

Nerve growth factor (NGF) expression in rat microglia is induced by adenosine A2a-receptors

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0651-7

21 January 2018

The kynurenine pathway and neurologic disease. Therapeutic strategies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18080815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quinolinic acid-induced lesions of the rat striatum: quantitative autoradiographic binding assessment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18080815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Both adenosine A1- and A2-receptors are required to stimulate microglial proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18080815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative assessment of quinolinic acid-induced striatal toxicity in rats using radioligand binding assays.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18080815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/18080815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic quinolinic acid lesions in rats closely resemble Huntington's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18080815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kynurenine pathway enzymes in brain. Properties of enzymes and regulation of quinolinic acid synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18080815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18080815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-007-0651-7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33310422&oldid=2195229831"